{"eventGroups":[{"deathsNumAffected":131,"deathsNumAtRisk":140,"description":"Gemcitabine + Paclitaxel until progression\n\nGemcitabine: 1000 mg/m² in IV infusion over 30-40 minutes at Day 1, 8 and 15 followed by one week of rest.\n\nPaclitaxel: 80 mg/m² in IV infusion over 60 minutes at Day 1, 8 and 15 followed by 1 week of rest.","id":"EG000","otherNumAffected":138,"otherNumAtRisk":140,"seriousNumAffected":71,"seriousNumAtRisk":140,"title":"GEMPAX"},{"deathsNumAffected":68,"deathsNumAtRisk":71,"description":"Gemcitabine alone until progression\n\nGemcitabine: 1000 mg/m² in IV infusion over 30-40 minutes at Day 1, 8 and 15 followed by one week of rest.","id":"EG001","otherNumAffected":22,"otherNumAtRisk":71,"seriousNumAffected":26,"seriousNumAtRisk":71,"title":"Control"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":140},{"groupId":"EG001","numAffected":3,"numAtRisk":71}],"term":"ANAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"FEBRILE NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"LYMPHOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":140},{"groupId":"EG001","numAffected":11,"numAtRisk":71}],"term":"NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":140},{"groupId":"EG001","numAffected":3,"numAtRisk":71}],"term":"THROMBOCYTOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CARDIAC FAILURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"APLASIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ABDOMINAL PAIN"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"DIARRHOEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NAUSEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"STOMATITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"VOMITING"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"ASTHENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"MUCOSAL INFLAMMATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CHOLESTASIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HEPATIC CYTOLISIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ALANINE AMINOTRANSFERASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"BLOOD ALKALINE PHOSPHATASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"GAMMA-GLUTAMYLTRANSFERASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PLATELET COUNT DECREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"DECREASED APPETITE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"MUSCULOSKELETAL PAIN"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"MYOSITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NEUROPATHY PERIPHERAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NEUROTOXICITY"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PARAESTHESIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PERIPHERAL SENSORY NEUTROPATHY"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"RENAL FAILURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"DYSPNOEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"INTERSITIAL LUNG DISEASE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ORGANISING PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PULMONARY EMBOLISM"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PULMONARY FIBROSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ALOPECIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"SKIN TOXICITY"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"ANAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"BICYTOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"FEBRILE NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"THROMBOCYTOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"ANGINA PECTORIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ATRIAL FIBRILLATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CARDIAC FAILURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"APLASIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"VISION BLURRED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"ABDOMINAL PAIN"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ANASTOMOTIC ULCER PERFORATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ASCITES"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"COLITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"GASTRIC HAEMORRHAGE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"GASTROINTESTINAL HAEMORRHAGE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"INTESTINAL OBSTRUCTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"MELAENA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"OESOPHAGEAL VARICES HAEMORRHAGE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PANCREATITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"SUBILEUS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"VOMITING"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ASTHENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"GENERA PHYSICAL HEALTH DETERIORATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HYPERTHERMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HYPOTHERMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"MUCOSAL INFLAMMATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PYREXIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"BILE DUCT STENOSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":3,"numAtRisk":71}],"term":"BILIARY OBSTRUCTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"CHOLANGITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CHOLECYSTITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CHOLECYSTITITS ACUTE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":2,"numAtRisk":71}],"term":"JAUNDICE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"BACTERAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"BILIARY SEPSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"BILIARY TRACT INFECTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CLOSTRIDIUM DIFFICILE COLITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"COVID-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"INJECTION SITE INFECTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"SEPSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"VASCULAR ACCESS SITE INFECTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"OVERDOSE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"SPINAL FRACTURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"WRIST FRACTURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"BLOOD BILIRUBIN INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"LIVER FUNCTION TEST ABNORMAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PLATELET COUNT DECREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"DECREASED APPETITE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"DIABETIC KETOACIDOSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HYPERCALCAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"STARVATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"MYOSITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CEREBRAL HAEMORRHAGE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"COMA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"DYSKINESIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HYPERAESTHESIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ISCHAEMIC STROKE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NERVOUS SYSTEM DISORDER"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"NEUROPATHY PERIPHERAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PSYCHOMOTOR SKILLS IMPAIRED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"SCIATICA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"TRANSIENT ISCHAEMIC ATTACK"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"CONFUSIONAL STATE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"HAEMATURIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":140},{"groupId":"EG001","numAffected":1,"numAtRisk":71}],"term":"RENAL FAILURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":3,"numAtRisk":71}],"term":"DYSPNOEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"INTERSTITIAL LUNG DISEASE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"ORGANISING PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PLEURAL EFFUSION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PULMONARY EMBOLISM"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PULMONARY FIBROSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":140},{"groupId":"EG001","numAffected":0,"numAtRisk":71}],"term":"PULMONARY OEDEMA"}],"timeFrame":"GEMPAX tracks adverse events for each participant from their first treatment dose, at day 1, day 8 and day 15 of each treatment cycle, and up to 30 days after the day of last treatment dose, approximatively 7 months."}